CVE-2025-37819

irqchip/gic-v2m: Prevent use after free of gicv2m_get_fwnode()

Description

In the Linux kernel, the following vulnerability has been resolved: irqchip/gic-v2m: Prevent use after free of gicv2m_get_fwnode() With ACPI in place, gicv2m_get_fwnode() is registered with the pci subsystem as pci_msi_get_fwnode_cb(), which may get invoked at runtime during a PCI host bridge probe. But, the call back is wrongly marked as __init, causing it to be freed, while being registered with the PCI subsystem and could trigger: Unable to handle kernel paging request at virtual address ffff8000816c0400 gicv2m_get_fwnode+0x0/0x58 (P) pci_set_bus_msi_domain+0x74/0x88 pci_register_host_bridge+0x194/0x548 This is easily reproducible on a Juno board with ACPI boot. Retain the function for later use.

N/A
CVSS
Severity:
EPSS 0.03%
Affected: Linux Linux
Affected: Linux Linux
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2025-37819?
CVE-2025-37819 has not yet been assigned a CVSS score.
How to fix CVE-2025-37819?
To fix CVE-2025-37819, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-37819 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-37819 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-37819?
CVE-2025-37819 affects Linux Linux, Linux Linux.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.